BACKGROUND: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has recently been utilized to accurately detect the amyloid proteins of renal amyloidosis. The present study investigated the optimal procedures for analyzing samples by LCMS/MS, and the advantage of using this technique to diagnosis renal amyloidosis. METHODS: To detect amyloid proteins, laser microdissected glomeruli from AL (n = 13) or AA (n = 10) renal amyloidosis patients were digested and analyzed by LCMS/MS. To determine the best procedures for analyzing samples by LCMS/MS, we examined the suitability of tissue samples, frozen or formalin-fixed paraffin-embedded (FFPE), the number of dissected glomeruli required for analysis (2, 10, or 50 glomeruli), and the amount of trypsin with or without dithiothreitol (DTT). We additionally compared the detection of amyloid proteins between immunostaining and LCMS/MS. RESULTS: Examining 10 dissected glomeruli from FFPE sections digested with trypsin 3 µL (0.1 mg/mL) without DDT made it possible to detect amyloid protein in all 10 AA and in 10 out of 12 AL amyloidosis cases. All AA amyloidosis cases were diagnosed using immunohistochemistry for amyloid A. With immunostaining, however, there were several inconclusive immunoglobulin and/or their light chain staining noted in the AA or AL amyloidosis cases. Even so, LCMS/MS was able to accurately detect amyloid protein in renal amyloidosis. CONCLUSION: The use of 10 laser microdissected glomeruli (170,000-220,000 µm2) with amyloid deposition from FFPE sections digested with trypsin 3 µL (0.1 mg/mL) allowed the accurate detection of amyloid protein in AA and AL amyloidosis.
BACKGROUND: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has recently been utilized to accurately detect the amyloid proteins of renal amyloidosis. The present study investigated the optimal procedures for analyzing samples by LCMS/MS, and the advantage of using this technique to diagnosis renal amyloidosis. METHODS: To detect amyloid proteins, laser microdissected glomeruli from AL (n = 13) or AA (n = 10) renal amyloidosispatients were digested and analyzed by LCMS/MS. To determine the best procedures for analyzing samples by LCMS/MS, we examined the suitability of tissue samples, frozen or formalin-fixed paraffin-embedded (FFPE), the number of dissected glomeruli required for analysis (2, 10, or 50 glomeruli), and the amount of trypsin with or without dithiothreitol (DTT). We additionally compared the detection of amyloid proteins between immunostaining and LCMS/MS. RESULTS: Examining 10 dissected glomeruli from FFPE sections digested with trypsin 3 µL (0.1 mg/mL) without DDT made it possible to detect amyloid protein in all 10 AA and in 10 out of 12 AL amyloidosis cases. All AA amyloidosis cases were diagnosed using immunohistochemistry for amyloid A. With immunostaining, however, there were several inconclusive immunoglobulin and/or their light chain staining noted in the AA or AL amyloidosis cases. Even so, LCMS/MS was able to accurately detect amyloid protein in renal amyloidosis. CONCLUSION: The use of 10 laser microdissected glomeruli (170,000-220,000 µm2) with amyloid deposition from FFPE sections digested with trypsin 3 µL (0.1 mg/mL) allowed the accurate detection of amyloid protein in AA and AL amyloidosis.
Entities:
Keywords:
Amyloid protein; Immunofluorescence; Immunohistochemistry; Liquid chromatography tandem mass spectrometry; Renal amyloidosis
Authors: Sanjeev Sethi; Jason D Theis; Nelson Leung; Angela Dispenzieri; Samih H Nasr; Mary E Fidler; Lynn D Cornell; Jeffrey D Gamez; Julie A Vrana; Ahmet Dogan Journal: Clin J Am Soc Nephrol Date: 2010-09-28 Impact factor: 8.237
Authors: Surendra Dasari; Md Shahrier Amin; Paul J Kurtin; Julie A Vrana; Jason D Theis; Karen L Grogg; Mariam P Alexander; Samih H Nasr; Fernando C Fervenza; Nelson Leung; Sanjeev Sethi Journal: Kidney Int Date: 2016-06-02 Impact factor: 10.612
Authors: Anjali A Satoskar; Kelly Burdge; Daniel J Cowden; Gyongyi M Nadasdy; Lee A Hebert; Tibor Nadasdy Journal: Arch Pathol Lab Med Date: 2007-06 Impact factor: 5.534
Authors: Sanjeev Sethi; Ladan Zand; An S De Vriese; Ulrich Specks; Julie A Vrana; Siddak Kanwar; Paul Kurtin; Jason D Theis; Andrea Angioi; Lynn Cornell; Fernando C Fervenza Journal: Nephrol Dial Transplant Date: 2017-01-01 Impact factor: 5.992
Authors: Sanjeev Sethi; Julie A Vrana; Jason D Theis; Nelson Leung; Anjali Sethi; Samih H Nasr; Fernando C Fervenza; Lynn D Cornell; Mary E Fidler; Ahmet Dogan Journal: Kidney Int Date: 2012-04-11 Impact factor: 10.612
Authors: Peter Mollee; Samuel Boros; Dorothy Loo; Jayde E Ruelcke; Vanessa A Lakis; Kim-Anh Lê Cao; Patricia Renaut; Michelle M Hill Journal: Clin Proteomics Date: 2016-10-27 Impact factor: 3.988
Authors: Michelle M Hill; Surendra Dasari; Peter Mollee; Giampaolo Merlini; Catherine E Costello; Bouke P C Hazenberg; Martha Grogan; Angela Dispenzieri; Morie A Gertz; Taxiarchis Kourelis; Ellen D McPhail Journal: Mayo Clin Proc Date: 2021-04-09 Impact factor: 11.104
Authors: Makiko Ogawa; Yukako Shintani-Domoto; Yoshiki Nagashima; Koji L Ode; Aya Sato; Yoshihiro Shimizu; Kenichi Ohashi; Michael H A Roehrl; Tetsuo Ushiku; Hiroki R Ueda; Masashi Fukayama Journal: PLoS One Date: 2020-07-01 Impact factor: 3.240
Authors: Graham W Taylor; Janet A Gilbertson; Rabya Sayed; Angel Blanco; Nigel B Rendell; Dorota Rowczenio; Tamer Rezk; P Patrizia Mangione; Diana Canetti; Paul Bass; Philip N Hawkins; Julian D Gillmore Journal: Kidney Int Rep Date: 2019-04-15